What happened
L&C BIO updated the terms of a new share issuance to raise US$108M, about 9.5% of its market value.
For context, this raise equals about 9.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$108M |
| vs. market value | 9.5% |
| Filed | 2026-10-12, [Amended] Material event report (paid-in and bonus issue) |
| Source | DART rcept 20261012000188 → open original filing |
Versions of this filing
- 2026-07-31Original
- 2026-09-02Amendment 1
- 2026-10-12Amendment 2 (this page)
Source: DART. Information only, not investment advice.